Compare · CVSA vs RCM
CVSA vs RCM
Side-by-side comparison of Covista Inc. (CVSA) and R1 RCM Inc. (RCM): market cap, price performance, sector, and recent activity on the wire.
Summary
- CVSA operates in Real Estate, while RCM operates in Consumer Discretionary - the two are in different parts of the market.
- RCM is the larger of the two at $6.21B, about 1.5x CVSA ($4.02B).
- CVSA has hit the wire 7 times in the past 4 weeks while RCM has been quiet.
- RCM has more recent analyst coverage (25 ratings vs 1 for CVSA).
- Company
- Covista Inc.
- R1 RCM Inc.
- Price
- $118.06+1.68%
- $14.32+0.07%
- Market cap
- $4.02B
- $6.21B
- 1M return
- +0.32%
- -
- 1Y return
- +1.65%
- -
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 0
- Recent ratings
- 1
- 25
R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.
Latest CVSA
- President, Chamberlain Univ. Manning Amelia was granted 4,317 shares (SEC Form 4)
- Chairman & CEO Beard, Stephen W. sold $702,401 worth of shares (5,291 units at $132.75) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 418,742 units (SEC Form 4)
- Covista and the Covista Foundation Commit $10 Million and 50,000 Volunteer Hours to Build and Sustain the Healthcare Workforce
- Chief Financial Officer Phelan Robert J. sold $719,499 worth of shares (5,314 units at $135.40) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 50,492 units (SEC Form 4)
- SVP, GC, Corp. Sec & ISS Beck Douglas G. sold $688,910 worth of shares (5,089 units at $135.37) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 33,070 units (SEC Form 4)
- Covista Announces Fourth Quarter and Fiscal Year 2026 Conference Call
- Covista and Advocate Health Launch Strategic Nursing Collaboration to Strengthen Workforce Readiness and Expand Patient Access
- Chairman & CEO Beard, Stephen W. sold $690,198 worth of shares (5,291 units at $130.45) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 424,033 units (SEC Form 4)
- SEC Form 11-K filed by Covista Inc.
- SEC Form 3 filed by new insider Manning Amelia
Latest RCM
- Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.
- Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)
- Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director Ashdown Clay
- SEC Form 4 filed by Director Wexler Erik G.
- SEC Form 4 filed by Director Nakis Dominic
- Director Bundy Scanlan Agnes returned $472,100 worth of shares to the company (33,014 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- Director Flanagan Joseph Gerard was granted 98,238 shares and returned $49,840,920 worth of shares to the company (3,485,379 units at $14.30), closing all direct ownership in the company (SEC Form 4)
- President Sparby John M. was granted 332,323 shares and returned $9,154,731 worth of shares to the company (640,191 units at $14.30), closing all direct ownership in the company (SEC Form 4)